Browser does not support script.
We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.
Scientists set to benefit from one of the biggest grants awarded by Cancer Research UK
New molecular mechanism revealed for genetic mutations in aggressive cancer cells
Scientists closer to understanding the role of certain genes in breast cancer
MP dons lab coat to learn how research saves lives
Life Sciences in Six - Dr Joanna Parish
My story: Graham Silk
Precision Medicine: Diagnostic medical genetics
Dr Andrew Peet - Support our brain cancer in children research
Posted 14 July 2017
The College of Medical and Dental Sciences is delighted to announce that at the University of Birmingham Founders' Awards for Excellence 2017, held on Thursday 12 July during the Chancellor's Dinner, colleagues from across the College were awarded three of the evening's four awards.
The National Institute for Health Research (NIHR) has awarded £7 million to the Universities of Birmingham, Edinburgh and Warwick to establish a joint research unit focussed on developing global surgical research.
Posted 26 June 2017
Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progression of the disease, according to new research by the Universities of Birmingham and Oxford.
Posted 12 June 2017
Researchers at the University of Birmingham have found that a type of protein could hold the secret to suppressing the growth of breast cancer tumours.
Posted 07 June 2017
One of the largest clinical trials for prostate cancer led by the University of Birmingham has found that adding Abiraterone to hormone therapy at the start of treatment improves survival by 37%.
View all news